Scholarly Index
Toby A. Eyre
Oxford University Hospitals NHS Trust; 5,052 total citations; 318 total publications; best world rank #10
Oxford University Hospitals NHS Trust
5,052Total citations
318Total publications
37H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 396 | GB 25 | 95.45 |
| Advanced Breast Cancer Therapies | Lifetime | 942 | GB 53 | 92.77 |
| Viral-associated cancers and disorders | 2021-2025 | 12 | GB 1 | 98.69 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 42 | GB 1 | 99.41 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 50 | GB 1 | 99.31 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 10 | GB 3 | 98.76 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 153 | GB 7 | 97.19 |
| CAR-T cell therapy research | 2021-2025 | 592 | GB 11 | 96.44 |
| Advanced Breast Cancer Therapies | 2021-2025 | 378 | GB 12 | 93.11 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 520 | GB 25 | 88.76 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 563 | GB 7 | 79.77 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 388 | GB 14 | 74.13 |